ABSTRACT
Extrarenal involvement was found in four cases of renal angiomyolipoma. In one case the wall of the inferior right bronchial artery was infiltrated, lymph nodes were involved in two cases and the perirenal fat in one case. Extrarenal extension does not seem to alter the prognosis of renal angiomyolipoma. Expectant treatment of this rare condition therefore appears to be warranted.
Subject(s)
Angiomyolipoma/pathology , Kidney Neoplasms/pathology , Lymphatic Metastasis , Vascular Neoplasms/secondary , Adult , Angiomyolipoma/physiopathology , Angiomyolipoma/surgery , Bronchial Arteries , Female , Humans , Kidney Neoplasms/physiopathology , Kidney Neoplasms/surgery , Lung Neoplasms/secondary , Male , Middle Aged , Neoplasm InvasivenessABSTRACT
Melanosis of the prostate gland is a rare pathological finding. Its clinical significance is unknown and the histogenesis is occult. It is found in benign prostatic hyperplasia or carcinoma of the prostate. We present such a case and review the literature.
Subject(s)
Melanosis/pathology , Prostatic Hyperplasia/pathology , Aged , Humans , Male , Melanosis/complications , Prostatic Hyperplasia/complicationsABSTRACT
The authors describe a case of inverted papilloma. It is relatively rare and generally appears as a benign tumour.
Subject(s)
Kidney Neoplasms/diagnosis , Kidney Pelvis , Papilloma/diagnosis , Humans , Male , Middle AgedABSTRACT
One thousand patients with renal stones up to 3 cm in diameter were divided equally into 2 groups matched for age, sex and stone size. One group was treated on the Dornier HM3 lithotriptor and the other on the EDAP LT01. The results showed that for stones less than 1 cm both lithotriptors were equally effective, with a stone-free rate of 87.5% for the Dornier and 90.4% for the EDAP at 3 months. The success rate fell more steeply for the EDAP machine, however, to become 77.2 and 42.5% respectively as the stone size increased to 3 cm. Treatment time was longer on the EDAP lithotriptor and more sessions were required but patients preferred it to the Dornier. Running costs per patient were higher on the EDAP.
